These preliminary findings suggest that including a measure of CRP improves the ability for clinicians to detect cases of mild‐to‐moderate OSA with true cardiometabolic risk, with implications in improving prognosis and treatment within this clinically gray area. Here, CRP is linked to obstructive sleep apnea syndrome.